Off The Hook Yachts Launches $25 Million IPO Amid Expanding Boat Market
North Carolina-based yacht retailer positions itself as the largest U.S. marine wholesaler – seeks public funding to accelerate growth.
Off The Hook Yachts (Off The...
Nasus Pharma Prepares for $11 Million U.S. IPO: Intranasal Drugmaker Aims for Market Entry with Epinephrine Powder Technology
An Israeli biotech firm with emergency care ambitions takes its case to Wall Street
Tel Aviv-based Nasus Pharma is moving forward with its U.S. public debut, targeting...
Coya Therapeutics, Inc. (COYY) IPO: A Clinical-Stage Biotech’s Bold Step onto Wall Street
A New Immunotherapy Challenger on Nasdaq
In 2025, Coya Therapeutics, Inc. (Nasdaq: COYY) — a Houston-based clinical-stage biotechnology company — completed its initial public offering,...
Rebellyous Foods, Inc. (RBLY) IPO: Plant-Based Protein Pioneer Makes a Public Debut
A Plant-Based Challenger Steps onto Wall Street
In mid-2025, Rebellyous Foods, Inc., a Seattle-based producer of plant-based meat alternatives, completed its initial public offering on...
Anew Health Eyes U.S. Market with $18.75M IPO on Nasdaq
The Hong Kong–based pain therapy provider seeks growth and credibility via American public listing
Anew Health, a Hong Kong–headquartered healthcare services company founded in 2007, is...
